Clear Search

Showing 1 result for “Cohen S.”.

Évaluation de la progression radiographique chez les patients atteints de polyarthrite rhumatoïde traités par tofacitinib dans des études à long terme

Rheumatology (Oxford). 2021;60(4):1708-1716.

Long-term evaluation of tofacitinib has found limited progression of structural damage in patients with RA treated with tofacitinib for up to 5 years. Similar results were also observed for patients receiving tofacitinib monotherapy or combination therapy for up to 3 years.It is well known that inflammation in RA leads to structural damage over time, and therapies such as DMARDS have the ability to reduce inflammation whilst inhibiting the progression of structural damage. In this study, van der...

Lire la Suite…